Tecan Group AG
Company Profile
Business description
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
Contact
Seestrasse 103
Mannedorf8708
CHET: +41 449228111
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
3,305
Stocks News & Analysis
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
stocks
Our top ASX picks in every sector
stocks
Tesla: Shares fall as deliveries come in below consensus
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,165.70 | 2.00 | 0.02% |
| CAC 40 | 8,271.08 | 362.34 | 4.58% |
| DAX 40 | 24,018.91 | 1,097.32 | 4.79% |
| Dow JONES (US) | 47,914.15 | 1,329.69 | 2.85% |
| FTSE 100 | 10,622.99 | 274.20 | 2.65% |
| HKSE | 25,893.02 | 776.49 | 3.09% |
| NASDAQ | 22,675.87 | 658.02 | 2.99% |
| Nikkei 225 | 56,308.42 | 2,878.86 | 5.39% |
| NZX 50 Index | 13,253.94 | 184.28 | 1.41% |
| S&P 500 | 6,777.13 | 160.28 | 2.42% |
| S&P/ASX 200 | 8,951.80 | 21.00 | -0.23% |
| SSE Composite Index | 3,995.00 | 104.83 | 2.69% |